Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedJan 29, 2026
DataAggregated Company Financials
Companies7878
  • 7D0.9%
  • 3M1.6%
  • 1Y14.4%
  • YTD1.8%

Over the last 7 days, the market has remained flat, although notably the Information Technology sector gained 3.6% in that time. Meanwhile, the market is actually up 14% over the past year. Looking forward, earnings are forecast to grow by 16% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 29 Jan 2026US$73.5tUS$23.3tUS$2.3t19.1x32.2x3.2x
Sat, 27 Dec 2025US$72.8tUS$23.2tUS$2.3t19.2x31.8x3.1x
Mon, 24 Nov 2025US$68.9tUS$23.1tUS$2.3t18.1x30.2x3x
Wed, 22 Oct 2025US$71.1tUS$22.7tUS$2.2t18.9x32.3x3.1x
Fri, 19 Sep 2025US$70.0tUS$22.9tUS$2.2t19.3x32x3.1x
Sun, 17 Aug 2025US$67.5tUS$23.0tUS$2.2t18.8x31.3x2.9x
Tue, 15 Jul 2025US$65.3tUS$22.5tUS$2.1t18.7x31.1x2.9x
Thu, 12 Jun 2025US$63.1tUS$22.5tUS$2.1t18.1x30x2.8x
Sat, 10 May 2025US$59.0tUS$22.4tUS$2.1t17.5x28.2x2.6x
Mon, 07 Apr 2025US$52.5tUS$21.9tUS$2.1t16.1x25.6x2.4x
Wed, 05 Mar 2025US$61.0tUS$21.9tUS$2.0t17.5x29.9x2.8x
Fri, 31 Jan 2025US$63.8tUS$22.1tUS$2.0t18.9x31.9x2.9x
Sun, 29 Dec 2024US$62.6tUS$22.0tUS$1.9t18.3x32.4x2.8x
Tue, 26 Nov 2024US$62.6tUS$22.0tUS$1.9t19.7x32.5x2.8x
Thu, 24 Oct 2024US$60.6tUS$21.6tUS$1.9t18.2x32.5x2.8x
Sat, 21 Sep 2024US$59.2tUS$21.5tUS$1.9t18.2x31.8x2.7x
Mon, 19 Aug 2024US$57.4tUS$21.5tUS$1.8t17.9x31.1x2.7x
Wed, 17 Jul 2024US$58.5tUS$21.3tUS$1.8t18.1x31.7x2.7x
Fri, 14 Jun 2024US$56.3tUS$21.3tUS$1.8t16.8x30.6x2.6x
Sun, 12 May 2024US$54.2tUS$21.2tUS$1.8t17.4x29.9x2.6x
Tue, 09 Apr 2024US$54.2tUS$21.1tUS$1.8t17.4x29.4x2.6x
Thu, 07 Mar 2024US$52.9tUS$21.1tUS$1.8t16.4x28.7x2.5x
Sat, 03 Feb 2024US$51.6tUS$21.1tUS$1.8t17x29.2x2.4x
Mon, 01 Jan 2024US$50.3tUS$21.0tUS$1.8t16.9x28.6x2.4x
Wed, 29 Nov 2023US$47.5tUS$21.1tUS$1.8t15.8x27.1x2.3x
Fri, 27 Oct 2023US$43.4tUS$21.0tUS$1.7t14.8x24.9x2.1x
Sun, 24 Sep 2023US$45.5tUS$20.9tUS$1.7t15.4x26.5x2.2x
Tue, 22 Aug 2023US$45.9tUS$20.9tUS$1.7t15.7x26.9x2.2x
Thu, 20 Jul 2023US$48.5tUS$21.0tUS$1.7t15.8x28.9x2.3x
Sat, 17 Jun 2023US$46.7tUS$21.0tUS$1.7t15.2x28.1x2.2x
Mon, 15 May 2023US$43.2tUS$21.0tUS$1.7t14.4x26x2.1x
Wed, 12 Apr 2023US$43.4tUS$20.6tUS$1.6t15.1x26.8x2.1x
Fri, 10 Mar 2023US$41.8tUS$20.6tUS$1.6t15x25.7x2x
Sun, 05 Feb 2023US$44.5tUS$20.5tUS$1.7t15.5x25.5x2.2x
Price to Earnings Ratio

25.5x


Total Market Cap: US$44.5tTotal Earnings: US$1.7tTotal Revenue: US$20.5tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 29.5x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 29.5x.
Past Earnings Growth
  • The earnings for American listed companies have grown 9.3% per year over the last three years.
  • Revenues for these companies have grown 4.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market0.90%
Tech3.55%
Telecom2.95%
Materials2.60%
Energy2.43%
Utilities0.59%
Consumer Discretionary-0.32%
Consumer Staples-0.87%
Financials-1.07%
Industrials-1.21%
Real Estate-1.99%
Healthcare-2.81%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.2x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 16.7%, which is higher than its past year's earnings growth of 14.1% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.8x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Consumer Staples sector is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MSFT MicrosoftUS$481.638.4%
+US$278.9b		8.9%PE34.1xTech
NVDA NVIDIAUS$191.523.6%
+US$162.3b		53.6%PE46.9xTech
META Meta PlatformsUS$668.739.1%
+US$140.6b		-1.1%PE28.8xTelecom
AAPL AppleUS$256.443.5%
+US$129.2b		7.1%PE33.6xTech
AMZN Amazon.comUS$243.013.7%
+US$92.7b		3.6%PE34xConsumer Discretionary
See more

Market Insights

Header cover image
How to invest when commodity prices get messy ⚖️
Richard Bowman avatar
Richard Bowman
|
|
From miners to energy, 2026 may reward structure and margins over spot price bets.
Continue reading
Why Didn’t Oil React to Venezuela? 🇻🇪
Last Week

Why Didn’t Oil React to Venezuela? 🇻🇪

Latest News

UNH
US$294.02
UnitedHealth Group
7D
-15.5%
1Y
-45.4%
META
US$668.73
Meta Platforms
7D
9.1%
1Y
-1.1%
AMZN
US$243.01
Amazon.com
7D
3.7%
1Y
3.6%
ANET
US$150.15
Arista Networks
7D
18.0%
1Y
39.2%
NVDA
US$191.52
NVIDIA
7D
3.6%
1Y
53.6%
MSFT
US$481.63
Microsoft
7D
8.4%
1Y
8.9%
ABT
US$106.05
Abbott Laboratories
7D
-12.2%
1Y
-17.1%

ABT: Exact Sciences Acquisition Will Shape Future Earnings Mix And Upside Potential

Analysts have reduced their fair value estimate for Abbott Laboratories by about $8 to $136.47, reflecting a series of recent price target cuts that incorporate slightly adjusted growth, discount rate and P/E assumptions, along with expectations for a modestly higher profit margin profile. Analyst Commentary Recent research updates show a mix of optimism and caution around Abbott Laboratories, with several firms adjusting price targets and factoring in the pending Exact Sciences acquisition.
GOOGL
US$336.01
Alphabet
7D
2.3%
1Y
72.0%
LLY
US$1,023.80
Eli Lilly
7D
-5.1%
1Y
27.3%

LLY: Government GLP 1 Pricing Deals Will Pressure Obesity Margins

Analysts have nudged their price targets on Eli Lilly slightly higher, citing continued confidence in the obesity and GLP 1 franchise, supportive government pricing agreements, and potential upside from acquisitions and pipeline catalysts, even as some firms fine tune their models and individual targets by low single digit amounts such as Guggenheim's recent US$2 trim. Analyst Commentary Recent research on Eli Lilly has been dominated by optimism around obesity treatments and government pricing agreements, but there is also a pocket of caution that is worth paying attention to if you are thinking about valuation, execution and long term growth risk.
INTC
US$48.78
Intel
7D
-10.2%
1Y
143.8%
BRK.A
US$709,500.00
Berkshire Hathaway
7D
-2.0%
1Y
0.7%
AAPL
US$256.44
Apple
7D
3.5%
1Y
7.1%

Maintaining FV - it's all coming true

Am maintaining my FV on this one. This video does a great job of explaining the many years of weak product innovation, which will be hard to recover from.
GE
US$292.48
General Electric
7D
-8.2%
1Y
46.9%

GE: Engine Contract Momentum And Higher Margins Will Support Future Returns

Narrative Update Analysts have made a modest upward adjustment to their price targets for General Electric, reflecting small refinements to assumptions on discount rate, revenue growth, profit margins, and future P/E rather than a change in the US$394 fair value estimate. Analyst Commentary Recent Street research around General Electric has centered on fine tuning price targets for GE Aerospace, with a mix of upward and downward adjustments that still point to generally constructive sentiment on the company’s execution and earnings power.
WMT
US$116.57
Walmart
7D
-2.3%
1Y
19.6%

WMT: AI Partnerships And New CEO Are Set To Balance Opportunities

Analysts have nudged our Walmart fair value estimate up to US$123.20 from about US$121.38, reflecting modestly higher assumptions for revenue growth, profit margins, and future P/E, following a series of upward price target revisions and constructive commentary on partnerships like Gemini and other alternative revenue streams. Analyst Commentary Recent research on Walmart has been active, with several firms updating price targets and framing the stock around its execution in core retail, newer revenue streams, and the upcoming CEO transition.
TSLA
US$431.46
Tesla
7D
-4.0%
1Y
7.8%

TSLA: Autonomy And Robotaxi Progress Will Reshape Long-Term Equity Story

Analysts have nudged their Tesla price targets higher by aligning models with slightly lower discount rates, marginally firmer revenue growth and profit margin assumptions, and a modestly reduced future P/E multiple. Recent research highlights both upside tied to full self driving and robotaxi potential, as well as ongoing concerns about auto fundamentals and execution risk.
MU
US$435.28
Micron Technology
7D
11.9%
1Y
389.0%

MU: AI Memory Supercycle Hype Will Eventually Meet New DRAM Capacity

Our fair value estimate for Micron Technology has been adjusted higher to US$176.14 from US$171.83, reflecting analysts' higher price targets and rationale around tight DRAM supply, strong AI driven memory demand, and expectations for improved margins and earnings power. Analyst Commentary Recent research has generally pointed to tight DRAM conditions, AI related memory demand, and constrained high bandwidth memory supply as key themes for Micron.